OSI Systems, Inc. Form 10-Q Summary
Business Context and Reporting Period
OSI Systems designs and manufactures specialized electronic systems and components and provides security screening services across Security, Healthcare, and Optoelectronics and Manufacturing segments. The filing covers the three months ended September 30, 2013, the first quarter of fiscal 2014, compared with the three months ended September 30, 2012. The financial statements are unaudited.
Key Financial Metrics
| Metric | Q1 FY2014 | Q1 FY2013 | Change |
|---|---|---|---|
| Total revenue | $206.3 million | $181.7 million | 14% |
| Gross profit | $67.9 million | $61.4 million | 11% |
| Gross margin | 32.9% | 33.8% | Down 0.9 percentage points |
| Operating income | $10.5 million | $10.1 million | 3% |
| Operating margin | 5.1% | 5.6% | Down 0.5 percentage points |
| Net income | $6.4 million | $6.3 million | 1% |
| Diluted EPS | $0.31 | $0.31 | No change |
| Cash flow from operations | $6.2 million | $42.4 million | Down $36.2 million |
Revenue growth was led by Security, up 17% to $97.2 million, and Optoelectronics and Manufacturing, up 25% to $71.3 million. Healthcare revenue declined 11% to $45.8 million. Services revenue increased to $62.8 million from $32.8 million, while product revenue declined to $143.5 million from $148.9 million.
Operating expenses rose to $57.5 million from $51.2 million, including $4.2 million of restructuring and other charges. SG&A increased 6% to $42.2 million, while research and development declined 3% to $11.0 million. The effective tax rate was 29.0%, compared with 29.7%.
Cash and cash equivalents were $37.2 million at September 30, 2013, compared with $34.7 million at June 30, 2013. Total assets were $952.8 million and total stockholders’ equity was $484.4 million. Inventories increased to $228.0 million from $206.2 million, primarily to support expected growth.
Total debt, including bank lines and current and long-term debt, was $94.2 million at September 30, 2013, compared with $71.5 million at June 30, 2013. Net debt increased to approximately $57.0 million from $36.8 million. The company had $79.0 million outstanding under its $425 million revolving credit facility and $120.4 million of outstanding letters of credit.
Material Changes Versus the Prior Comparable Period
- Revenue increased 14%, with growth in Security and Optoelectronics and Manufacturing more than offsetting the Healthcare decline.
- Gross margin declined because of the lower contribution from higher-margin Healthcare products and the greater mix of lower-margin Optoelectronics and Manufacturing revenue.
- Operating income grew only modestly because of restructuring and contract-settlement charges totaling $4.2 million, including $1.6 million related to a Transportation Security Administration contract settlement.
- Cash generated from operations fell sharply because working capital used $18.9 million of cash, including a $16.1 million inventory increase. The prior-year period benefited from $27.2 million of working-capital cash generation.
- Investing cash use declined to $19.0 million from $66.0 million, reflecting lower capital expenditures of $8.0 million versus $62.7 million, partly offset by $9.3 million spent on acquisitions.
- Debt increased primarily to fund the Mexico turnkey screening program, capital expenditures, acquisitions, and other corporate activities.
Outlook, Risks, Contingencies, and Unusual Items
Management stated that available funds, credit facilities, and operating cash flow are expected to satisfy operational cash needs for the foreseeable future. The company has no current plan to pay cash dividends and disclosed no significant off-balance-sheet arrangements.
- Management cited uncertainty from the U.S. federal government shutdown, budget and debt-ceiling debates, sequestration, and potential changes in government spending. These factors could materially affect Security results and cash flows.
- Healthcare demand remains pressured by hospital capital-spending delays, economic conditions, healthcare reform uncertainty, reimbursement issues, and potential medical-device fees. Management anticipates lower healthcare sales than historically experienced during this period.
- Foreign exchange, geopolitical conditions, international regulations, customer collections, and tariffs remain material risks. A 10% appreciation of the U.S. dollar was estimated to increase quarterly operating income by approximately $2 million; a 10% depreciation would have the opposite effect.
- The company had approximately $4.0 million of foreign-currency forward contracts and an interest-rate swap associated with variable-rate debt outstanding at September 30, 2013.
- Contingent consideration obligations had a maximum potential future payment of $52 million; $21.4 million was recorded in other long-term liabilities.
- A $100 million advance from the Mexican government supported a turnkey security-screening agreement; $95.8 million remained outstanding and subject to a company guarantee.
- The company is investigating soil and groundwater contamination at its Hawthorne, California facility. No environmental liability was accrued because management considered an unfavorable outcome not probable and reasonably estimable, but an adverse resolution could be material.
- Ordinary-course legal proceedings were not expected by management to have a material adverse effect, although adverse outcomes could affect liquidity or results materially.
- Restructuring activities included a completed Healthcare facility relocation and an Optoelectronics and Manufacturing facility consolidation expected to be completed during fiscal 2014.
Most Important Facts for Investors to Verify
- Whether the substantial increase in services and Security revenue is sustainable, particularly the Mexico turnkey screening program.
- Whether Healthcare revenue and margins recover from the reported declines.
- Inventory growth, working-capital conversion, and the ability to restore operating cash flow.
- Debt and letter-of-credit utilization, covenant compliance, variable interest-rate exposure, and refinancing needs before the November 2016 credit-facility maturity.
- The ultimate cost and timing of TSA contract-settlement obligations, restructuring actions, contingent acquisition payments, and the Mexican customer advance guarantee.
- Potential financial exposure from the Hawthorne environmental investigation and other unaccrued legal or environmental contingencies.
- Management’s statement that disclosure controls were effective as of September 30, 2013 and that no material changes occurred in internal control over financial reporting.